| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13G · 3 securities · passive | ||||||
|
Soligenix, Inc.
13G/A
SNGX · 834223604
|
9.4% |
11/2/2026
Event 9/30/2026
|
||||
| MJL Manager LLC | 9.4% | |||||
| Michael Liu | 9.4% | |||||
| Capuchin Capital Fund LP | 9.4% | |||||
|
Arcadia Biosciences, Inc.
13G
RKDA · 039014303
|
15.7% |
9/30/2026
Event 9/25/2026
|
||||
| MJL Manager LLC | 15.7% | |||||
| Michael Liu | 15.7% | |||||
| Capuchin Capital Fund LP | 15.7% | |||||
|
Xenetic Biosciences, Inc.
13G
XBIO · 984015602
|
0% |
9/18/2026
Event 9/16/2026
|
||||
| MJL Manager LLC | 0% | |||||
| Michael Liu | 0% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.